STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more

The FDA approved a Denali medicine for Hunter syndrome, a notable decision as the agency has recently taken tougher stances on rare disease drugs